Improvement seen in quality of life and reduction in specific symptoms for adolescent and young adult breast cancer survivors
FRIDAY, Dec. 12, 2025 (HealthDay News) — For adolescent and young adult (AYA) breast cancer (BC) survivors, a scalable mobile health intervention improves quality of life and reduces specific symptoms, according to a study presented at the annual San Antonio Breast Cancer Symposium, held from Dec. 9 to 12 in San Antonio.
Ann H. Partridge, M.D., M.P.H., from the Dana-Farber Cancer Institute in Boston, and colleagues conducted a multicenter, randomized controlled trial of the Young, Empowered & Strong (YES) intervention that offers tailored information, resources, and support based on monthly electronic patient-reported outcomes surveillance, together with an expressive writing platform and monitored chat room, in AYA BC survivors. After completing a baseline survey, 360 participants (median age at diagnosis, 34 years) were randomly assigned to YES and usual care (179 and 181, respectively).
The researchers found that baseline-adjusted differences in quality of life from baseline to six months were significantly different between the arms, favoring the YES arm for general and cancer-specific quality of life (difference, −4.87 and −3.16, respectively). Greater improvement of specific symptoms was seen on the Breast Cancer Prevention Trial symptom scales at six months favoring the YES arm (vaginal problems and arm problems: unadjusted difference in mean changes, −0.57 and −0.39, respectively). Modest improvements in fatigue were seen based on baseline-adjusted six-month changes in Patient-Reported Outcomes Measurement Information System-Fatigue, which also favored the YES arm (difference, −1.48).
“This type of intervention has the potential to improve the health and well-being of several other hard-to-reach populations, such as busy young adults and rural Americans who are less able to engage in person with cancer center resources and support,” Partridge said in a statement.
Gap Found Between Awareness of Breast Cancer Risk and Risk-Reducing Behavior
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder
Exercise Intervention Linked to Improved Attention, Memory in Breast Cancer
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy
Ultrasound-Guided Hydrodissection Yields Improvements in Carpal Tunnel
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis